Vaxxinity
  • Our Science
    • Our Platform
    • Our Publications
  • Our Lab
  • News
    • News Releases

Vaxxinity's COVID Booster Succeeds in Ph3

Best-in-class, long-lasting, well tolerated, cost-effective, and effective against emerging variants with no frozen cold chain, mRNA, or spike protein.

Read Article in the Lancet
Read All News
Vaxxinity

2622 Commerce St., Dallas, TX 75226

Copyright © 2026 Vaxxinity